The significance of changes in tumor hypoxia by anti-PD-1 / PD-L1 antibody therapy for advanced non-small cell lung cancer.

Not Applicable

• Conditions: advanced non-small cell lung cancer

• Registration Number: JPRN-UMIN000041659
• Lead Sponsor: Saitama Medical University International Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-09-03
• Study Completion: 2023-03-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1. Pregnant women, lactating women and women with the possibility or intention of becoming pregnant 2. Patients with complications that require intravenous administration of antibiotics and antifungal agents 3.Patients who need to administer systemic steroids and other immunosuppressive drugs 4. Patients with diabetes 5. In addition, patients who are judged as inappropriate by the doctor's judgment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change of SUVmax, MTV and TLG of FMISO accumulation on PET